Cancer therapy-related cardiac dysfunction (CTRCD) presents a significant challenge for both oncology and cardiology, necessitating a comprehensive understanding of its pathophysiology, risk factors, diagnostic modalities, and pharmacological interventions. Th... ...

请注册登录后继续浏览